Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
City of Hope Medical Center
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Gustave Roussy, Cancer Campus, Grand Paris
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Virginia
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Goethe University
Northwestern University
PETHEMA Foundation
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Northwestern University
Roswell Park Cancer Institute
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of California, San Francisco